NCT06876961

Brief Summary

This study will be done to investigate the effect of arm cycling on exercise and functional capacity, arterial blood gases, pulmonary functions, diaphragmatic excursion, time to peak inspiratory amplitude, physical function, anxiety, and depression after colectomy in the elderly.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 14, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

1 year

First QC Date

March 7, 2025

Last Update Submit

March 13, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Assessing the change of forced vital capacity using spirometry

    It will be conducted noninvasively using a spirometer, measuring: forced vital capacity (FVC) in Litres is known as total exhaled volume.

    At baseline and at the day 5 post-operative

  • Assessment of change of functional capacity

    A 6-minute stepper test is proposed to evaluate exercise tolerance using a standardized protocol. The test measures the number of steps performed on a stepper in 6 minutes, equivalent to the 6-minute walk test. Patients are accustomed to the stepper for 2 minutes, followed by a 3-minute rest and 6-minute stepping period. Heart rate and oxygen saturation are monitored, and an investigator stays behind the patient throughout the test.

    At baseline and at the day 5 post-operative

  • Assessment of change of diaphragmatic excursion using ultrasonography

    Participants undergo ultrasonography to measure diaphragmatic excursion In centimeters (cm) . The measurement will be performed using a 1- to 5-MHz ultrasound transducer in M-mode.

    At baseline and at the day 5 post-operative

  • Assessment of change of diaphragmatic excursion using ultrasonography

    Participants undergo ultrasonography to measure the Time-to-peak inspiratory amplitude (TPIAdia) of the diaphragm during tidal breathing in seconds (sec) of each hemidaphragm ( right and left ). The measurement will be performed using a 1- to 5-MHz ultrasound transducer in M-mode.

    At baseline and at the day 5 post-operative

  • Assessing the change of forced expiratory volume in 1 second using spirometry

    It will be conducted noninvasively using a spirometer, measuring: 2-forced expiratory volume in 1 second (FVC1) in liters is known as volume exhaled in the first second.

    At baseline and at the day 5 post-operative

Secondary Outcomes (8)

  • Assessment of change of potential of partial pressure of oxygen

    At baseline and at the day 5 post-operative

  • Assessment of change of bicarbonate (HCO₃)

    At baseline and at the day 5 post-operative

  • Assessment of change of anxiety

    At baseline and at the day 5 post-operative

  • Assessment of change of depression

    At baseline and at the day 5 post-operative

  • Assessment of change of physical function in intensive care unit tested scored (PFIT)

    At baseline and at the day 5 post-operative

  • +3 more secondary outcomes

Study Arms (2)

Arm cycling exercise

EXPERIMENTAL

The study group, including 30 participants, will do 20 minutes of arm cycling exercise plus the traditional physical therapy program.

Other: Arm cycling exerciseOther: The traditional physical therapy program

traditional physical therapy

ACTIVE COMPARATOR

The control group, including 30 participants, will do the traditional physical therapy program only

Other: The traditional physical therapy program

Interventions

The study involves a 20-minute arm cycling exercise twice daily for five days, starting with a warming-up and ending with a cooling-down. The workload is gradually increased to 60-70% of maximal heart rate, with patients sitting on a back support chair with 20 degrees backward inclination.

Arm cycling exercise

The patient undergoes 10 minutes of deep diaphragmatic breathing exercises, 10 minutes of spirometer training, 3-set ankle pump and heel slide exercises, 10-minute sitting on the bed edge, 5 minutes of walking in the intensive care unit, and 3-set active free range of motion exercises.

Arm cycling exercisetraditional physical therapy

Eligibility Criteria

Age65 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsSixty male patients who received a surgical removal of a diagnosed colon cancer (i.e., including right, transverse, left, sigmoid, subtotal, total, and hemicolectomy) will be included.
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Sixty male patients who received a surgical removal of a diagnosed colon cancer (i.e., including right, transverse, left, sigmoid, subtotal, total, and hemicolectomy) will be included.
  • Patients with a histologically confirmed diagnosis of primary colon or rectal neoplasm.
  • Colectomy isolated surgeries.
  • Patients will be included in this study after the immediate admission to the intensive care unit.
  • The age of patients will be ≥ 65 years old.
  • Patients' body mass index will be \< 30 Kg/m2.
  • All patients will be conscious, medically stable, and able to respond to the given commands fully.
  • Patients who voluntarily cooperated with this study
  • Karnofsky Performance Status \> 60 and able to walk ≥ 60 m. The Karnosky Performance Status is one of the most used validated scales to define the functional status of a cancer patient. A Karnofsky Performance Status ≤ 60 indicates the inability to work and severe difficulty in carrying out activities of daily living and personal care of the cancer patient Before surgeries

You may not qualify if:

  • Men who will meet one of the following criteria will be excluded:
  • relapsing cancer or metastasis cancer; simultaneous diagnosis of other neoplasms.
  • Cardiac disease patients.
  • Chronic inflammatory autoimmune disease
  • Patients with neurological conditions limit the performance of exercises.
  • Patients with diagnosed psychogenic diseases.
  • Patients with musculoskeletal disorders that interfere with performing exercise programs.
  • Chronic obstructive pulmonary disease, Asthma, hemodynamically unstable, significant arrhythmias, and any chronic lung disease.
  • Patients require invasive/noninvasive ventilatory support.
  • regular use of immunosuppressive drugs.
  • Patients with cognitive disorders and unstable hemodynamics.
  • patients suffering from brain death; or respiratory failure; ventilator-dependent patients: patients receiving palliative care or patients on tracheostomy.
  • inability to understand given information due to language or intellectual barriers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the intensive care unit of King Hamad University Hospital,

Al Muharraq, Bahrain

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Central Study Contacts

Israa Mohamed Abdelmoneim Youssef, physical therapist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 7, 2025

First Posted

March 14, 2025

Study Start

March 1, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

March 14, 2025

Record last verified: 2025-03

Locations